Effect of combination therapy with pioglitazone and acarbose on the progression of early atherosclerosis in type 2 diabetes patients

Journal of the Japan Diabetes Society

Volumn 49, Issue 3, 2006, Pages 197-204

  Yokoyama, Hiroki ^a   Kuramitsu, Masae ^a   Yokota, Yuki ^a   Tada, Junko ^a   Kamikawa, Futayo ^a   Kanno, Sakiko ^a   Matsushima, Masato ^b  

^a Yokoyama Jiyugaoka Clinic   (Japan)

^b JIKEI UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Acarbose; Arteriosclerosis; Intima media thickness (IMT); Pioglitazone; Type 2 diabetes mellitus

Indexed keywords

ACARBOSE; ALBUMIN; ANTIDIABETIC AGENT; C REACTIVE PROTEIN; CHOLESTEROL; HEMOGLOBIN A1C; INSULIN; PIOGLITAZONE; TRIACYLGLYCEROL;

ARTICLE; ATHEROSCLEROSIS; BLOOD PRESSURE; CHOLESTEROL BLOOD LEVEL; DIET THERAPY; DISEASE COURSE; DISEASE DURATION; HUMAN; NON INSULIN DEPENDENT DIABETES MELLITUS; PULSE WAVE; URINARY EXCRETION;

EID: 33646804182     PISSN: 0021437X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (20)

1. Haffner SM, Lehto S, Ronnemaa T, Pyorala K, Laakso M (1998) Mortality from coronary heart disease in subjects with type 2 diabetes and in nondiabetic subjects with and without prior myocardial infarction. N Engl J Med 339: 229-234
2. Kawamori R (1998) Asymptomatic hyperglycemia and early atherosclerotic changes. Diabetes Res Clin Pract 40(suppl): S 35-S 42
3. Yokoyama H, Aoki T, Imahori M, Kuramitsu M (2004) Subclinical atherosclerosis is increased in type 2 diabetic patients with microalbuminuria evaluated by intima-media thickness and pulse wave. Kidney Int 66: 448-54
4. Bots ML, Hoes AW, Koudstaal PJ (1997) Common carotid intima-media thickness and risk of stroke and myocardial infarction: the Rotterdam Study. Circulation 96: 1432-1437
5. Lehmann ED (1999) Clinical value of aortic pulse-wave velocity measurement. Lancet 354: 528-529
6. van Popele NM, Grobbee DE, Bots ML (2001) Association between arterial stiffness and atherosclerosis: the Rotterdam Study. Stroke 32: 454-460
7. Bots ML, Dijk JM, Oren A, Grobbee DE (2002) Carotid intima-media thickness and risk of cardiovascular disease: current evidence. J Hypertens 20: 2317-2325
8. Zureik M, Touboul PJ, Bonithon-Kopp C (1999) Cross-sectional and 4-year longitudinal associations between brachial pulse pressure and common carotid intima-media thickness in a general population. The EVA study. Stroke 30: 550-555, 1999
9. Diamant M, Heine RJ (2003) Thiazolidiones in type 2 diabets mellitus: current clinical evidence. Drugs 63: 1373-1405
10. Hanefeld M, Cagatay M, Petrowitsch T, Neuser D, Petzinna D, Rupp M (2004) Acarbose reduces the risk for myocardial infarction in type 2 diabetic patients: meta-analysis of seven long-term studies. Eur Heart J 25: 10-16
11. Cerielo A (2003) The possible role of postprandial hyperglycaemia in the pathogenesis of diabetic complications. Diabetologia 46(suppl 1): M 9-16
12. Ross R (1999) Atherosclerosis: an inflammatory disease. N Engl J med 340: 115-126
13. Zelen M (1979) A new design for randomized clinical trials. N Engl J Med 300: 1242-1245
14. Sidhu JS, Kaposzta Z, Markus HS, Kaski JC (2004) Effect of rosiglitazone on common carotid intima-media thickness progression in coronary artery disease patients without diabetes mellitus. Arterioscler Thromb Vasc Biol 24: 930-934
15. Langenfeld MR, Forst T, Hohberg C, Kann P, Pfutzner A (2005) Pioglitazone decreases carotid intima-media thickness independently of glycemic control in patients with type 2 diabetes mellitus. Circulation 111: 2525-2531
16. Nakamura T, Matsuda T, Kawagoe Y, Ogawa H, Takahashi Y, Sekinuka K, Koide H (2004) Effect of pioglitazone on carotid intima-media thickness and arterial stiffness in type 2 diabetic nephropathy patients. Metabolism 53: 1382-1386
17. Hanefeld M, Chiasson JL, Koehler C, Henkel E, Schaper F (2004) Acarbose slows progression of intima-media thickness of the carotid arteries in subjects with impaired glucose tolerance. Stroke 35: 1073-1078
18. Yamasaki Y, Katakami N, Hayaishi-Okano R, Matsushima M, Kajimoto Y, Kosugi K, Hatano M, Hori M (2005) α-glucosidase inhibitor reduces the progression of carotid intima-media thickness. Diabetes Res Clin Pract 67: 204-210
19. Yamasaki Y, Kodama M, Nishizawa H, Sakamoto K, Matsushima M, Kajimoto Y, Kosugi K, Shimizu Y, Kawamori R, Hori M (2000) Carotid intima-media thickness in Japanese type 2 diabetic subjects. Diabetes Care 23: 1310-1315
20. Satoh N, Ogawa Y, Usui T, Tagami T, Kono S, Uesugi H, Sugiyama H, Sugawara A, Yamada K, Shimatsu A, Kuzuya H, Nakao K (2003) Antiatherogenic effect of pioglitazone in type 2 diabetic patients irrespective of the responsiveness of its antidiabetic effect. Diabetes Care 26: 2493-2499